Your browser doesn't support javascript.
loading
A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants.
Kim, Dong-Gun; Kim, Uijin; Park, In Ho; Ryu, Bumhan; Yoo, Youngki; Cha, Jeong Seok; Yoon, Ga-Yeon; Kim, Sung-Hee; Oh, Heeju; Seo, Jun-Young; Nam, Ki Taek; Seong, Je Kyung; Shin, Jeon-Soo; Cho, Hyun-Soo; Kim, Hak-Sung.
Affiliation
  • Kim DG; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, South Korea.
  • Kim U; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.
  • Park IH; Institute of Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, 03722, South Korea; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Ryu B; Institute for Basic Science (IBS), Daejeon, 34126, South Korea.
  • Yoo Y; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.
  • Cha JS; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.
  • Yoon GY; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.
  • Kim SH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Oh H; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Seo JY; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Nam KT; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, South Korea; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Seong JK; Korea Mouse Phenotyping Center, Seoul National University, Seoul, 08826, South Korea.
  • Shin JS; Department of Microbiology, Yonsei University College of Medicine, Seoul, 03722, South Korea; Institute of Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, 03722, South Korea; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03
  • Cho HS; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea. Electronic address: hscho8@yonsei.ac.kr.
  • Kim HS; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, South Korea. Electronic address: hskim76@kaist.ac.kr.
Antiviral Res ; 220: 105738, 2023 12.
Article in En | MEDLINE | ID: mdl-37944822
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article Affiliation country: South Korea Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article Affiliation country: South Korea Country of publication: Netherlands